glp 1 eye problems Wegovy Vision Loss Lawsuit [2026 Update] Ozempic Blindness: Should You Worry?

MASH typically develops in individuals with obesity, insulin resistance, and metabolic syndrome

In those situations, clinician-prescribed injectables studied and approved for weight management are usually the safer, better-supported option

A major clinical trial showed patients taking oral semaglutide lost approximately 35% of their body weight over 26 weeks, with some individuals achieving greater reductions through consistent diet and exercise adherence

10.1172/JCI133473 137 LiR.XuW.LuoS.XuH.TongG.ZengL.et al (2015)

Acknowledgements Figures are created with BioRender.com

Association of type 2 diabetes with liver cirrhosis: a nationwide cohort study